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Abstract 
Background: Vascular endothelial growth factor-A (VEGFA) is the main mediator of angiogenesis. 
Angiogenesis plays important roles not only in many physiological processes, but also in the 
pathophysiology of many diseases. VEGFA is one of the therapeutic targets of treatment for ocular 
diseases with neovascularization. Therefore, elucidation of the regulatory mechanisms for VEGFA 
expression is important for the development of pharmaceutical drugs. Recent studies have 
demonstrated that the unfolded protein response is involved in the transcriptional regulation of 
VEGFA. However, the precise regulation of VEGFA in the human retina is not fully understood. 
Principal Findings: When human retinal pigment epithelial cells, ARPE-19, were exposed to 
endoplasmic reticulum stressors, VEGFA mRNA was significantly upregulated. The unfolded 
protein response-related transcription factors XBP1, ATF4, ATF6, and OASIS were expressed in 
ARPE-19 cells. To determine which transcription factors preferentially contribute to the induction of 
VEGFA expression after endoplasmic reticulum stress, we carried out reporter assays using an 
approximately 6-kbp 5’-upstream region of the human VEGFA gene. Among these transcription 
factors, OASIS acted most effectively on the VEGFA promoter in ARPE-19 cells. Based on data 
obtained for certain deleted and mutated reporter constructs, we determined that OASIS promoted 
VEGFA expression by acting on a cyclic AMP-responsive element-like site located at around –500 
bp relative to the VEGFA transcription start site. Furthermore, we confirmed that OASIS directly 
bound to the promoter region containing this site by chromatin immunoprecipitation assays. 
Conclusions and Significance: We have demonstrated a novel regulatory mechanism for VEGFA 
transcription by OASIS in human retinal pigment epithelial cells. Chemical compounds that regulate 
the binding of OASIS to the promoter region of the VEGFA gene may have potential as therapeutic 
agents for ocular diseases with neovascularization. 
 
